| ➡️ Get instant news updates on Whatsapp. Click here to join our Whatsapp Group. |
Galaxy Medicare has released IPO and all details of IPO such as last date to apply, price, prospectus PDF and all other details are given below.
Galaxy Medicare IPO Details
| IPO Open Date | September 10, 2025 |
| IPO Close Date | September 12, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹51 to ₹54 Per Share |
| Issue Size | Approx ₹22.31 Crores |
| Fresh Issue | Approx ₹17.86 Crores |
| Offer for Sale | Approx 8,24,000 Equity Shares |
| Lot Size | 2,000 Shares |
| Issue Type | Book Built Issue |
| IPO Listing | NSE SME |
| Download Prospectus PDF | Click Here |
Galaxy Medicare IPO Dates and Schedule
| IPO Open Date | September 10, 2025 |
| IPO Close Date | September 12, 2025 |
| Basis of Allotment | September 15, 2025 |
| Refunds | September 16, 2025 |
| Credit to Demat Account | September 16, 2025 |
| IPO Listing Date | September 17, 2025 |
| IPO Bidding Cut-off Time | September 12, 2025 – 5 PM |
About Galaxy Medicare IPO
Galaxy Medicare Limited, incorporated in July 1992, is engaged in manufacturing and exporting medical devices, POP bandages, and surgical dressings in India. The company uses high-quality raw materials sourced from trusted vendors to ensure reliable products. It specializes in surgical dressings, plaster of Paris bandages, adhesive tapes, compression bandages, wound care solutions, gauze products, and orthopedic items. Over the years, Galaxy Medicare has built strong flagship brands such as POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE, GYPSONET, GYPSOCHLOR, and FIXCAN. Along with its own brands, it also undertakes OEM manufacturing, where it produces and tests products as per brand owners’ specifications. The company participates in government tenders through the GEM portal, exports its products internationally, and trades surgical dressings and devices.
With 27 registered trademarks in India, Galaxy Medicare has a strong presence both domestically and globally. Its products are widely accepted by the medical community and are supplied to government health departments, corporate hospitals, and private healthcare institutions across the country. The company holds ISO 9001:2015 and ISO 13485:2016 certifications, ensuring its products meet strict international healthcare standards. As of March 2025, it employs around 190 people across different departments. Its strengths lie in experienced leadership, skilled management, strong customer relationships, adherence to quality standards, a well-established manufacturing setup with a wide product range, in-house quality assurance and research facilities, and a growing presence in international markets.
-
-
-
-
-
-
-
-
-
-
-
-
